Background Despite increasing recognition of the value of real-world data (RWD),
consensus on the definition of RWD is lacking. Objectives To review definitions publicly …

The growing worldwide population has increased the need for technologies, computerised
software algorithms and smart devices that can monitor and assist patients anytime and …

Background Wearable technology has shown the potential of improving healthcare
efficiency and reducing healthcare cost. Different from pioneering studies on healthcare …

Background Randomized controlled trials provide robust data on the efficacy of interventions
rather than on effectiveness. Health technology assessment (HTA) agencies worldwide are …

Purpose The effect of the transition toward digital technologies on today's businesses (ie
Industry 4.0 transition) is becoming increasingly relevant, and the number of studies that …

As policy-makers and business practitioners across the globe expend extraordinary effort
toward the field of e-health, the thriving development of healthcare-wearable technology is …

Stakeholders in healthcare are increasingly turning to real world evidence (RWE) to inform
their decisions, alongside evidence from randomized controlled trials. RWE is generated by …

Accurately estimating personalized treatment effects within a study site (eg, a hospital) has
been challenging due to limited sample size. Furthermore, privacy considerations and lack …

There is growing interest in leveraging real-world data to complement knowledge gained
from randomized clinical trials and inform the design of prospective randomized studies in …

Background Patient survival in advanced/metastatic melanoma, non‐small cell lung cancer
(NSCLC), and renal cell carcinoma (RCC) has improved with immune checkpoint inhibitors …